SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-19-088540
Filing Date
2019-03-27
Accepted
2019-03-27 16:27:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d727928d424b5.htm 424B5 380867
2 GRAPHIC g727928g28u31.jpg GRAPHIC 47247
3 GRAPHIC g727928g33q91.jpg GRAPHIC 41162
  Complete submission text file 0001193125-19-088540.txt   503874
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-228581 | Film No.: 19708637
SIC: 3826 Laboratory Analytical Instruments